Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... use among cytotoxic agents was found for exposure to cyclophosphamide (OR, 3.58; 95% CI, 0.91-14.11) followed by mitoxantrone ...

    Research Article last updated 02/21/2017 - 10:55am.

  2. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

    ... included. The conditioning regimen included busulfan, cyclophosphamide and thymoglobulin (ATG). The recipients received ...

    Research Article last updated 02/01/2017 - 12:30pm.

  3. High-Dose Cyclophosphamide in Comparison with Antithymocyte Globulin for Treatment of Acquired Severe Aplastic Anemia

    ... A modified high-dose cyclophosphamide (HD-CTX) plus cyclosporine (CsA) regimen was ...

    Research Article last updated 02/04/2013 - 1:55pm.

  4. Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

    ... depletion. The conditioning regimen included busulfan/ cyclophosphamide and antithymocyte globulin . Fifty-one patients ...

    Research Article last updated 01/24/2017 - 11:52am.

  5. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

    ... Conditioning regimens consisting of reduced-dose cyclophosphamide (CY) and fludarabine (FDR) have been investigated ...

    Research Article last updated 03/06/2014 - 11:00am.

  6. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    ... line therapy of aplastic anemia with high dose cyclophosphamide causes toxicity and increased short-term mortality. We investigated cyclophosphamide at a lower "moderate" dose, in combination with aggressive ...

    Research Article last updated 09/24/2014 - 10:17am.

  7. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

    ... results of a novel conditioning regimen of reduced dose cyclophosphamide (Cy, 25 mg/kg for four days), fludarabine (Flu, 30 ...

    Research Article last updated 05/14/2013 - 1:00pm.

  8. Strong results for SAA patients at Johns Hopkins

    ... patients received high doses of the chemotherapy drug cyclophosphamide . For the next year, or slightly longer, they remained on ... more than 95 percent," says Brodsky. The idea of using cyclophosphamide after a partial-match transplant was first pioneered decades ...

    Article last updated 02/07/2017 - 11:05am.

  9. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... use among cytotoxic agents was found for exposure to cyclophosphamide (OR, 3.58; 95% CI, 0.91-14.11) followed by mitoxantrone ...

    Research Article last updated 02/03/2017 - 1:25pm.

  10. Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

    ... treatment. Recently, fludarabine , lower-dose cyclophosphamide and antithymocyte globulin conditioning ...

    Research Article last updated 11/28/2016 - 9:28am.